1 not yet recruiting, 1 recruiting, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Unresectable Cervical Carcinoma: new trials by email Literature Review of Unresectable Cervical Carcinoma trials Research Report on Unresectable Cervical Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Phase 2 | Not yet recruiting | Fred Hutchinson Cancer Center | 50 | 2026-12-01 | 2026-09-17 |
| STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma Aldesleukin, Biopsy, Biospecimen Collection - Locally Advanced Cervical Carcinoma, Locally Advanced Colorectal Carcinoma | Phase 1 | Withdrawn | City of Hope Medical Center | 2025-12-05 | 2025-12-24 | |
| Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 138 | 2022-03-31 | 2026-08-20 |
Carcinoma, Renal Cell (3) · Melanoma (3) · Neoplasm Metastasis (3) · Uterine Cervical Neoplasms (3) · Carcinoma, Merkel Cell (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Transitional Cell (2) · Colorectal Neoplasms (2) · Lung Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Carcinoma, Basal Cell (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Lobular (1) · Carcinosarcoma (1) · Clear-cell metastatic renal cell carcinoma (1)
Adenocarcinoma (3) · Carcinoma (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Kidney Diseases (3) · Kidney Neoplasms (3) · Male Urogenital Diseases (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3)
Magnetic Resonance Spectroscopy (3) · Specimen Handling (3) · Biopsy (2) · Cyclophosphamide (2) · Colony-Stimulating Factors (1) · Immunoglobulin G (1) · Nivolumab (1) · X-Rays (1) · aldesleukin (1) · fludarabine (1) · pembrolizumab (1) · sargramostim (1)
City of Hope Medical Center (1) · Fred Hutchinson Cancer Center (1) · Mayo Clinic (1)
Uganda (1) · United States (1)
Shailender Bhatia, MD (1) · Vincent Chung (1) · Yanyan Lou, MD, PhD (1)
P30CA033572 (1)